Susquehanna International Group’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.2K Buy
41,584
+22,815
+122% +$21.3K ﹤0.01% 12772
2025
Q4
$29.1K Buy
18,769
+165
+0.9% +$264 ﹤0.01% 11885
2025
Q3
$29.4K Sell
18,604
-115,218
-86% -$200K ﹤0.01% 11981
2025
Q2
$292K Sell
133,822
-2,509
-2% -$6.08K ﹤0.01% 10403
2025
Q1
$372K Buy
136,331
+33,153
+32% +$131K ﹤0.01% 9580
2024
Q4
$429K Buy
103,178
+83,969
+437% +$317K ﹤0.01% 9047
2024
Q3
$74.7K Buy
19,209
+2,577
+15% +$10.9K ﹤0.01% 11201
2024
Q2
$65.2K Sell
16,632
-22,680
-58% -$97.6K ﹤0.01% 11291
2024
Q1
$165K Sell
39,312
-18,209
-32% -$85.5K ﹤0.01% 10810
2023
Q4
$270K Buy
57,521
+38,251
+199% +$149K ﹤0.01% 10041
2023
Q3
$60.1K Sell
19,270
-23,745
-55% -$95.5K ﹤0.01% 11208
2023
Q2
$197K Sell
43,015
-84,115
-66% -$387K ﹤0.01% 10287
2023
Q1
$629K Buy
127,130
+39,419
+45% +$194K ﹤0.01% 8005
2022
Q4
$479K Sell
87,711
-33,968
-28% -$208K ﹤0.01% 7973
2022
Q3
$791K Buy
121,679
+104,120
+593% +$581K ﹤0.01% 7258
2022
Q2
$83K Buy
17,559
+7,061
+67% +$34.8K ﹤0.01% 11641
2022
Q1
$73K Sell
10,498
-3,722
-26% -$25.4K ﹤0.01% 12105
2021
Q4
$145K Buy
+14,220
New +$153K ﹤0.01% 11829

Other funds holding MXCT

Susquehanna International Group's MXCT Position: Q1 2026 in Review

Susquehanna International Group increased its MaxCyte (MXCT) stake by 122% in Q1 2026, buying an estimated $21.3K and bringing the position to 41,584 shares worth $29.2K. The position accounts for ﹤0.01% of the portfolio, ranked #12772.

Susquehanna International Group first reported a position in MXCT in Q4 2021 and has held it in 18 quarters since. The position peaked at $791K in Q3 2022. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • Susquehanna International Group held 41,584 shares of MaxCyte worth $29.2K as of Q1 2026.
  • Susquehanna International Group bought 22,815 MaxCyte shares in Q1 2026, an estimated $21.3K.
  • MaxCyte made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12772 holding.
  • Susquehanna International Group first reported a position in MaxCyte in Q4 2021 and has held it in 18 quarters since.
  • Susquehanna International Group's MaxCyte position peaked at $791K in Q3 2022.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.